Evolent Health announced an agreement to expand its technology and services solution for oncology with existing partner Centene.
Centene will expand its use of Evolent Health’s oncology solution across its Centene and WellCare Medicare Advantage members nationally. This agreement deepens the specialty care partnership between Centene and Evolent in the MA market.
For over twenty years through its technology & services offering, Evolent has provided a platform to payers that helps drive clinical quality and financial accountability for total oncology spending. Read more.
